INTEGRAGEN (ALINT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:ALINT - FR0010908723 - Common Stock
0.155 EUR
0 (-1.27%)
ALINT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 85 industry peers in the Biotechnology industry. While ALINT seems to be doing ok healthwise, there are quite some concerns on its profitability. ALINT is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- ALINT had negative earnings in the past year.
- In the past 5 years ALINT reported 4 times negative net income.
- ALINT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- ALINT's Return On Assets of -42.94% is on the low side compared to the rest of the industry. ALINT is outperformed by 60.00% of its industry peers.
- ALINT's Return On Equity of -442.86% is on the low side compared to the rest of the industry. ALINT is outperformed by 65.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.94% | ||
| ROE | -442.86% | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ALINT has a Gross Margin of 59.49%. This is comparable to the rest of the industry: ALINT outperforms 50.59% of its industry peers.
- In the last couple of years the Gross Margin of ALINT has declined.
- ALINT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 59.49% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-1.96%
2. Health
2.1 Basic Checks
- ALINT has about the same amout of shares outstanding than it did 1 year ago.
- ALINT has more shares outstanding than it did 5 years ago.
- ALINT has a better debt/assets ratio than last year.
2.2 Solvency
- ALINT has an Altman-Z score of -0.78. This is a bad value and indicates that ALINT is not financially healthy and even has some risk of bankruptcy.
- The Altman-Z score of ALINT (-0.78) is comparable to the rest of the industry.
- ALINT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.78 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- ALINT has a Current Ratio of 1.04. This is a normal value and indicates that ALINT is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.04, ALINT is not doing good in the industry: 68.24% of the companies in the same industry are doing better.
- A Quick Ratio of 0.96 indicates that ALINT may have some problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 0.96, ALINT is doing worse than 67.06% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.04 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
- ALINT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2200.00%.
- ALINT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -39.29%.
- ALINT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.99% yearly.
EPS 1Y (TTM)-2200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-950%
Revenue 1Y (TTM)-39.29%
Revenue growth 3Y-8.41%
Revenue growth 5Y0.99%
Sales Q2Q%-43.98%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for ALINT. In the last year negative earnings were reported.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
- ALINT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
INTEGRAGEN / ALINT.PA FAQ
What is the fundamental rating for ALINT stock?
ChartMill assigns a fundamental rating of 2 / 10 to ALINT.PA.
Can you provide the valuation status for INTEGRAGEN?
ChartMill assigns a valuation rating of 0 / 10 to INTEGRAGEN (ALINT.PA). This can be considered as Overvalued.
How profitable is INTEGRAGEN (ALINT.PA) stock?
INTEGRAGEN (ALINT.PA) has a profitability rating of 0 / 10.
How financially healthy is INTEGRAGEN?
The financial health rating of INTEGRAGEN (ALINT.PA) is 5 / 10.